MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-01-2026
China Pharma Holdings ROA Ratio 2011-2026 | CPHI
Annual ROA Ratio China Pharma Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.28 | -31.81 | -18.69 | -22.34 | -15.01 | -13.58 | -93.1 | -23.69 | -32.15 | -11.69 | -15.85 | -19.72 | -12.69 | 2.83 | 12.32 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.32 | -93.1 | -20.36 |
Quarterly ROA Ratio China Pharma Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.79 | -25.97 | -32.21 | -18.39 | -23.45 | -20.21 | -13.91 | -11.58 | -16.46 | -16.28 | -17.46 | -14.73 | -19.28 | -18.94 | -18.12 | -12.55 | -17.33 | -17.57 | -13.37 | -7.85 | -11.0 | -9.37 | -13.2 | -8.8 | -12.89 | -13.83 | -12.28 | -6.96 | -10.62 | -10.19 | -11.79 | -9.09 | -11.32 | -9.89 | -9.2 | -7.33 | -4.32 | 0.93 | 5.21 | -0.01 | -5.24 | -13.48 | -21.78 | -14.34 | -20.42 | -21.27 | -16.96 | -8.73 | -5.14 | 4.53 | 10.16 | 8.11 | 10.21 | 8.73 | 9.17 | 8.61 | 2.1 | 3.24 | 3.26 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.21 | -32.21 | -9.87 |
ROA Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-48.08 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-61.13 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
-110.24 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-2.52 | $ 3.16 | 2.35 % | $ 44.4 M | USA |
 |
Cronos Group
CRON
|
-3.8 | $ 2.57 | -0.58 % | $ 1.33 B |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-34.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-8.75 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
-2.16 | $ 5.64 | 0.45 % | $ 2.06 B | Canada |
 |
Harrow Health
HROW
|
-1.29 | $ 36.11 | 0.5 % | $ 1.33 B | USA |
 |
Aurora Cannabis
ACB
|
-26.69 | $ 3.39 | -1.31 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.05 | -0.48 % | $ 113 M | Canada |
 |
OrganiGram Holdings
OGI
|
-23.59 | $ 1.41 | 0.36 % | $ 402 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-31.31 | - | - | $ 193 M | Canada |
 |
Jupiter Wellness
JUPW
|
-166.41 | - | - | $ 33.6 M | USA |
 |
Relmada Therapeutics
RLMD
|
-61.05 | $ 7.22 | -0.96 % | $ 285 M | USA |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
-22.86 | $ 4.22 | -1.17 % | $ 272 M | USA |
 |
Emergent BioSolutions
EBS
|
-41.71 | $ 7.97 | 0.13 % | $ 408 M | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.37 | -3.5 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
-33.73 | $ 6.49 | -1.29 % | $ 4.01 B | Canada |
 |
Organogenesis Holdings
ORGO
|
0.17 | $ 2.35 | -1.22 % | $ 309 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 24.02 | 0.97 % | $ 1.11 B | USA |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Veru
VERU
|
-62.57 | $ 2.34 | -1.68 % | $ 316 M | USA |
 |
Viatris
VTRS
|
4.16 | $ 13.57 | 0.74 % | $ 16.3 B | USA |
 |
ProPhase Labs
PRPH
|
21.06 | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
-1.44 | $ 0.7 | 4.98 % | $ 3.02 M | USA |
 |
Assertio Holdings
ASRT
|
-11.38 | $ 18.04 | 0.08 % | $ 116 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-32.94 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-14.58 | $ 1.02 | 1.74 % | $ 50.9 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-74.97 | $ 7.75 | -3.43 % | $ 678 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 2.31 | 1.32 % | $ 2.87 M | USA |
 |
Zomedica Corp.
ZOM
|
-64.44 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-9.3 | $ 0.91 | 0.05 % | $ 32.7 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
-1.51 | $ 1.97 | -4.83 % | $ 22.8 M | USA |